B2M |
B2M, CDABP0092, HDCMA22P: Beta-2-microglobulin precursor [Contains: Beta-2-micro |
CD47 |
CD47, MER6: Leukocyte surface antigen CD47 precursor |
0.295 |
Evidence |
|
IPO7 |
IPO7: Uncharacterized protein IPO7 |
MATR3 |
MATR3, KIAA0723: Matrin-3 |
0.295 |
Evidence |
|
VIL2 |
IPI00479359 |
HLA-DPB1 |
HLA-DPB1: MHC class II lymphocyte antigen beta chain precursor |
0.295 |
Evidence |
|
TRIM28 |
TRIM28, KAP1, RNF96, TIF1B: Transcription intermediary factor 1-beta |
DPF2 |
DPF2, REQ, UBID4: Zinc finger protein ubi-d4 |
0.295 |
Evidence |
|
HLA-A |
HLA-A, HLAA: HLA class I histocompatibility antigen, A-3 alpha chain precursor |
NCF1 |
Neutrophil cytosolic factor 1 variant (Fragment) |
0.295 |
Evidence |
|
PCBP1 |
PCBP1: Poly(rC)-binding protein 1 |
RBM14 |
RBM14, SIP: RNA-binding protein 14 |
0.295 |
Evidence |
|
MMP2 |
MMP2, CLG4A: 72 kDa type IV collagenase precursor |
MPZL1 |
MPZL1, PZR, UNQ849/PRO1787: Myelin protein zero-like protein 1 precursor |
0.295 |
Evidence |
|
ICAM3 |
ICAM3: Intercellular adhesion molecule 3 precursor |
SYK |
SYK: Tyrosine-protein kinase SYK |
0.295 |
Evidence |
|
SIRPB1 |
SIRPB1: Signal regulatory protein beta-1 precursor |
HCK |
IPI00029769 |
0.295 |
Evidence |
|
MS4A1 |
MS4A1, CD20: B-lymphocyte antigen CD20 |
BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
0.295 |
Evidence |
|
EPHA4 |
EPHA4, HEK8, SEK, TYRO1: Ephrin type-A receptor 4 precursor |
SPTAN1 |
IPI00413728 |
0.295 |
Evidence |
|
GRAP2 |
GRAP2, GADS, GRB2L, GRID: GRB2-related adapter protein 2 |
CBLB |
CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B |
0.295 |
Evidence |
|
NCF1 |
Neutrophil cytosolic factor 1 variant (Fragment) |
LILRB1 |
IPI00385703 |
0.295 |
Evidence |
|
FLII |
FLII, FLIL: Protein flightless-1 homolog |
FADD |
FADD, MORT1: Protein FADD |
0.295 |
Evidence |
|
RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
HMGN2 |
HMGN2, HMG17: Non-histone chromosomal protein HMG-17 |
0.295 |
Evidence |
|
CD58 |
CD58, LFA3: Lymphocyte function-associated antigen 3 precursor |
FNBP1 |
IPI00102670 |
0.295 |
Evidence |
|
ITGAV |
ITGAV, MSK8, VNRA: Integrin alpha-V precursor |
FSTL1 |
FSTL1, FRP: Follistatin-related protein 1 precursor |
0.295 |
Evidence |
|
HLA-DMB |
HLA-DMB, DMB, RING7: HLA class II histocompatibility antigen, DM beta chain prec |
BLNK |
BLNK, BASH, SLP65: B-cell linker protein |
0.295 |
Evidence |
|
HLA-DPB1 |
HLA-DPB1: MHC class II lymphocyte antigen beta chain precursor |
FNBP1 |
IPI00102670 |
0.295 |
Evidence |
|
FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
HLA-DMB |
HLA-DMB, DMB, RING7: HLA class II histocompatibility antigen, DM beta chain prec |
0.295 |
Evidence |
|
RANGAP1 |
RANGAP1, SD: Ran GTPase-activating protein 1 |
ANP32B |
ANP32B, APRIL, PHAPI2: Acidic leucine-rich nuclear phosphoprotein 32 family memb |
0.295 |
Evidence |
|
JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
CRLF3 |
IPI00295387 |
0.295 |
Evidence |
|
CD59 |
CD59, MIC11, MIN1, MIN2, MIN3, MSK21: CD59 glycoprotein precursor |
HSPG2 |
HSPG2: Basement membrane-specific heparan sulfate proteoglycan core protein prec |
0.295 |
Evidence |
|
BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
LILRB1 |
IPI00385703 |
0.295 |
Evidence |
|
HLA-B |
HLA-B, HLAB: HLA class I histocompatibility antigen, B-7 alpha chain precursor |
PTEN |
PTEN, MMAC1, TEP1: Phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase and du |
0.295 |
Evidence |
|